Kanis JA - Search Results

1

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis.

Wu CH, Hung WC, Chang IL, Tsai TT, Chang YF, McCloskey EV, Watts NB, McClung MR, Huang CF, Chen CH, Wu KL, Tsai KS, Chan DC, Chen JF, Tu ST, Hwang JS, Xia W, Matsumoto T, Chung YS, Cooper C, Kanis JA, Yang RS, Chan WP. Wu CH, et al. Among authors: kanis ja. Bone Rep. 2020 Oct 27;13:100729. doi: 10.1016/j.bonr.2020.100729. eCollection 2020 Dec. Bone Rep. 2020. PMID: 33195764 Free PMC article.

2

Epidemiology of vertebral osteoporosis.

Kanis JA, McCloskey EV. Kanis JA, et al. Bone. 1992;13 Suppl 2:S1-10. doi: 10.1016/8756-3282(92)90189-4. Bone. 1992. PMID: 1385718 Review.

3

Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption.

Taube T, Beneton MN, McCloskey EV, Rogers S, Greaves M, Kanis JA. Taube T, et al. Among authors: kanis ja. Eur J Haematol. 1992 Oct;49(4):192-8. doi: 10.1111/j.1600-0609.1992.tb00046.x. Eur J Haematol. 1992. PMID: 1464362

4

Osteoporotic fractures: an unusual presentation of haemochromatosis.

Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE, Kanis JA. Eyres KS, et al. Among authors: kanis ja. Bone. 1992;13(6):431-3. doi: 10.1016/8756-3282(92)90086-c. Bone. 1992. PMID: 1476821

5

Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).

Eyres KS, Marshall P, McCloskey E, Douglas DL, Kanis JA. Eyres KS, et al. Among authors: kanis ja. Drug Saf. 1992 Mar-Apr;7(2):162-5. doi: 10.2165/00002018-199207020-00008. Drug Saf. 1992. PMID: 1605902

6

Stanozolol stimulates remodelling of trabecular bone and net formation of bone at the endocortical surface.

Benéton MN, Yates AJ, Rogers S, McCloskey EV, Kanis JA. Benéton MN, et al. Among authors: kanis ja. Clin Sci (Lond). 1991 Oct;81(4):543-9. doi: 10.1042/cs0810543. Clin Sci (Lond). 1991. PMID: 1657503

7

Treatment of skeletal disease in breast cancer with clodronate.

Paterson AH, Ernst DS, Powles TJ, Ashley S, McCloskey EV, Kanis JA. Paterson AH, et al. Among authors: kanis ja. Bone. 1991;12 Suppl 1:S25-30. doi: 10.1016/8756-3282(91)90063-o. Bone. 1991. PMID: 1720012 Review.

8

Rationale for the use of bisphosphonates in bone metastases.

Kanis JA, McCloskey EV, Taube T, O'Rourke N. Kanis JA, et al. Bone. 1991;12 Suppl 1:S13-8. doi: 10.1016/8756-3282(91)90061-m. Bone. 1991. PMID: 1954047 Review.

9

Use of diphosphonates in hypercalcaemia due to malignancy.

Kanis JA, McCloskey EV, Paterson AH. Kanis JA, et al. Lancet. 1990 Jan 20;335(8682):170-1. Lancet. 1990. PMID: 1967461 No abstract available.

10

Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.

Bickerstaff DR, O'Doherty DP, McCloskey EV, Hamdy NA, Mian M, Kanis JA. Bickerstaff DR, et al. Among authors: kanis ja. Bone. 1991;12(1):17-20. doi: 10.1016/8756-3282(91)90049-o. Bone. 1991. PMID: 2054231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

877 results

Search Page

Filters